Ellen Matloff

6.1k total citations · 2 hit papers
45 papers, 4.0k citations indexed

About

Ellen Matloff is a scholar working on Genetics, Cancer Research and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Ellen Matloff has authored 45 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Genetics, 10 papers in Cancer Research and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Ellen Matloff's work include BRCA gene mutations in cancer (37 papers), Genomics and Rare Diseases (7 papers) and Genomic variations and chromosomal abnormalities (7 papers). Ellen Matloff is often cited by papers focused on BRCA gene mutations in cancer (37 papers), Genomics and Rare Diseases (7 papers) and Genomic variations and chromosomal abnormalities (7 papers). Ellen Matloff collaborates with scholars based in United States, United Kingdom and Austria. Ellen Matloff's co-authors include D. Gareth Evans, Claudine Isaacs, Henry T. Lynch, Susan L. Neuhausen, Timothy R. Rebbeck, Mary B. Daly, Olufunmilayo I. Olopade, Judy E. Garber, Steven A. Narod and Tara M. Friebel and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Ellen Matloff

45 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prophylactic Oophorectomy in Carriers ofBRCA1orBRCA2Mutations

2002 1.0k citations Timothy R. Rebbeck, Henry T. Lynch et al. New England Journal of Medicine profile →
Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group

2004 812 citations Timothy R. Rebbeck, Tara M. Friebel et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ellen Matloff United States	22	3.3k	1.2k	1.1k	856	853	45	4.0k
Mary B. Daly United States	18	3.0k 0.9×	963 0.8×	969 0.9×	768 0.9×	744 0.9×	36	3.6k
Charmaine Kim‐Sing Canada	34	2.2k 0.7×	1.1k 0.9×	681 0.6×	1.2k 1.5×	567 0.7×	61	3.7k
Noah D. Kauff United States	31	3.3k 1.0×	1.3k 1.1×	2.2k 2.1×	1.3k 1.6×	1.2k 1.4×	91	5.1k
Christi J. van Asperen Netherlands	36	2.4k 0.7×	708 0.6×	423 0.4×	818 1.0×	564 0.7×	104	3.4k
Margreet G.E.M. Ausems Netherlands	35	2.0k 0.6×	769 0.6×	362 0.3×	1.0k 1.2×	638 0.7×	157	3.6k
Fiona Lalloo United Kingdom	39	2.4k 0.7×	1.5k 1.2×	434 0.4×	1.7k 2.0×	1.6k 1.9×	119	5.0k
Jessica B. Mandell United States	17	2.4k 0.7×	853 0.7×	499 0.5×	734 0.9×	596 0.7×	28	3.6k
Ketil Heimdal Norway	29	1.5k 0.5×	787 0.7×	343 0.3×	1.0k 1.2×	1.1k 1.3×	103	3.6k
Ulf Kristoffersson Sweden	33	1.9k 0.6×	631 0.5×	213 0.2×	745 0.9×	935 1.1×	156	4.2k
Siranoush Manoukian Italy	26	1.3k 0.4×	798 0.7×	444 0.4×	637 0.7×	435 0.5×	81	2.6k

Countries citing papers authored by Ellen Matloff

Since Specialization

Citations

This map shows the geographic impact of Ellen Matloff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Matloff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Matloff more than expected).

Fields of papers citing papers by Ellen Matloff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen Matloff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Matloff. The network helps show where Ellen Matloff may publish in the future.

Co-authorship network of co-authors of Ellen Matloff

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen Matloff. A scholar is included among the top collaborators of Ellen Matloff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen Matloff. Ellen Matloff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cragun, Deborah, Jason W. Beckstead, Meagan Farmer, et al.. (2021). IMProving care After inherited Cancer Testing (IMPACT) study: protocol of a randomized trial evaluating the efficacy of two interventions designed to improve cancer risk management and family communication of genetic test results. BMC Cancer. 21(1). 1099–1099. 5 indexed citations

Farmer, Meagan, Suzanne M. Mahon, Maria J. Baker, et al.. (2019). Errors in Genetic Testing: The Fourth Case Series. The Cancer Journal. 25(4). 231–236. 38 indexed citations

Voznesensky, Olga, et al.. (2017). Challenges in Interpreting Germline Mutations in BARD1 and ATM in Breast and Ovarian Cancer Patients. The Breast Journal. 23(4). 461–464. 6 indexed citations

Matloff, Ellen, Rachel Barnett, & Robert L. Nussbaum. (2014). Choosing a BRCA Genetic Testing Laboratory: A Patient-Centric and Ethical Call to Action for Clinicians and Payers. The American Journal of Managed Care. 20. 1 indexed citations

Matloff, Ellen. (2014). The Angelina Effect: Rising Interest in Genetic Testing Creates Opportunities for Patients-and Profit. The American Journal of Managed Care. 20. 1 indexed citations

Brierley, Karina L., et al.. (2014). “Would you test your children without their consent?” and other sticky dilemmas in the field of cancer genetic testing. Familial Cancer. 13(3). 345–350. 2 indexed citations

Brierley, Karina L., Rachel Barnett, Talia Donenberg, et al.. (2014). Adverse Events in Cancer Genetic Testing. The Cancer Journal. 20(4). 246–253. 40 indexed citations

Brierley, Karina L., et al.. (2012). Adverse Events in Cancer Genetic Testing. The Cancer Journal. 18(4). 303–309. 83 indexed citations

Domchek, S. M., Tara M. Friebel, Susan L. Neuhausen, et al.. (2011). Is hormone replacement therapy (HRT) following risk-reducing salpingo-oophorectomy (RRSO) in BRCA1 (B1)- and BRCA2 (B2)-mutation carriers associated with an increased risk of breast cancer?. Journal of Clinical Oncology. 29(15_suppl). 1501–1501. 16 indexed citations

10.

Haffty, Bruce G., Doo Ho Choi, Sharad Goyal, et al.. (2009). Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups. Annals of Oncology. 20(10). 1653–1659. 51 indexed citations

11.

Kauff, Noah D., Susan M. Domchek, Tara M. Friebel, et al.. (2008). Risk-Reducing Salpingo-Oophorectomy for the Prevention of BRCA1- and BRCA2-Associated Breast and Gynecologic Cancer: A Multicenter, Prospective Study. Journal of Clinical Oncology. 26(8). 1331–1337. 381 indexed citations

12.

Friebel, Tara M., Susan M. Domchek, Susan L. Neuhausen, et al.. (2007). Bilateral Prophylactic Oophorectomy and Bilateral Prophylactic Mastectomy in a Prospective Cohort of Unaffected BRCA1 and BRCA2 Mutation Carriers. Clinical Breast Cancer. 7(11). 875–882. 67 indexed citations

13.

Domchek, Susan M., Tara M. Friebel, Susan L. Neuhausen, et al.. (2006). Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study. The Lancet Oncology. 7(3). 223–229. 216 indexed citations

14.

Matloff, Ellen. (2006). Becoming a Daughter. Journal of Genetic Counseling. 15(3). 139–143. 5 indexed citations

15.

Higgins, Susan A., Ellen Matloff, David L. Rimm, et al.. (2005). Patterns of reduced nipple aspirate fluid production and ductal lavage cellularity in women at high risk for breast cancer. Breast Cancer Research. 7(6). R1017–22. 24 indexed citations

16.

Zhou, Xiao-Ping, Kristin Waite, Robert Pilarski, et al.. (2003). Germline PTEN Promoter Mutations and Deletions in Cowden/Bannayan-Riley-Ruvalcaba Syndrome Result in Aberrant PTEN Protein and Dysregulation of the Phosphoinositol-3-Kinase/Akt Pathway. The American Journal of Human Genetics. 73(2). 404–411. 199 indexed citations

17.

Rebbeck, Timothy R., Henry T. Lynch, Susan L. Neuhausen, et al.. (2002). Prophylactic Oophorectomy in Carriers ofBRCA1orBRCA2Mutations. New England Journal of Medicine. 346(21). 1616–1622. 1025 indexed citations breakdown →

18.

Haffty, Bruce G., Atif J. Khan, Pradip M. Pathare, et al.. (2002). Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status. The Lancet. 359(9316). 1471–1477. 206 indexed citations

19.

Matloff, Ellen. (2000). The breast surgeon’s role in BRCA1 and BRCA2 testing. The American Journal of Surgery. 180(4). 294–298. 12 indexed citations

20.

Matloff, Ellen, et al.. (1996). Framework for a proactive parent support group: The syracuse cystic fibrosis model. Journal of Pediatric Health Care. 10(6). 264–271. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact